Target assessment via RNA sequencing and IHC confirmed the presence of SIRPα in bulk tumor samples from various solid and hematologic malignancies, and SIRPα expression correlated with the presence of macrophages. The gene discussed is SIRPA; the disease is hematologic disorder.